Pasithea Therapeutics Corp.
KTTA
$0.77
-$0.03-4.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.91% | 14.46% | 17.88% | 16.44% | 12.89% |
| Total Depreciation and Amortization | 2.05% | 2.79% | -0.18% | -0.09% | 0.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 472.11% | 22.35% | -39.38% | 75.30% | 171.47% |
| Change in Net Operating Assets | 79.04% | 147.50% | -201.11% | -127.31% | -196.52% |
| Cash from Operations | -9.25% | 20.33% | 16.30% | 11.86% | -3.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21,322,233.33% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -109.92% | -109.53% | -- | 103,385.71% | -- |
| Cash from Financing | 1,306.03% | 55.76% | 403.93% | 249.99% | 221.23% |
| Foreign Exchange rate Adjustments | 852.00% | 268.73% | 240.43% | 9.52% | 37.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 613.77% | 49.75% | 95.98% | 62.76% | 43.85% |